Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events.
Andreas EdsfeldtPratibha SinghFrank MatthesChristoffer TengrydMichele CavaleraEva BengtssonPontus DunérPetr VolkovGlykeria KaradimouAnton GisteråMarju Orho-MelanderJan NillsonJiangming SunIsabel GonçalvesPublished in: Cardiovascular research (2023)
TGF-β2 is the most abundant TGF-β isoform in human plaques and may maintain plaque stability by decreasing inflammation and matrix degradation.